Towards Healthcare
In Vitro Release Testing (IVRT) Market Establish USD 252.64 Mn by 2034

In Vitro Release Testing (IVRT) Market Report 2025 Emerging Tech & CRO Demand Push Rapid Growth

Market insights predict the global in vitro release testing (IVRT) industry will increase from USD 65.55 million in 2024 to USD 252.64 million by 2034, achieving a CAGR of 14.47%.The market is growing due to rising demand for bioequivalent testing in generic and topical formulations. Regulatory pressure for accurate, non-clinical drug evaluation is also fueling its expansion.

Content

  • Insight Code: 5931
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The in vitro release testing (IVRT) market is projected to reach USD 252.64 million by 2034, growing at a CAGR of 14.47% from 2024 to 2034.

North America is currently leading the healthcare cybersecurity market due to its well-established pharmaceutical industry, advanced research infrastructure, and strong regulatory framework supporting in vitro testing methods.

Some key players include Waters Corporation, Agilent Technologies Inc., Shimadzu Corporation, Analytical Technologies Ltd, and Distek Inc. 

Key trends include the growth due to rising demand for bioequivalent testing in generic and topical formulations.

IVRT measures the drug release from a formulation, while IVPT evaluates how much of the drug permeates through biological membranes like human or animal skin.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions